264 related articles for article (PubMed ID: 9614375)
1. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity.
Eerola AK; Törmänen U; Rainio P; Sormunen R; Bloigu R; Vähäkangas K; Lehto VP; Soini Y; Pääkkö P
J Pathol; 1997 Feb; 181(2):172-7. PubMed ID: 9120721
[TBL] [Abstract][Full Text] [Related]
5. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas.
Jiang SX; Sato Y; Kuwao S; Kameya T
J Pathol; 1995 Oct; 177(2):135-8. PubMed ID: 7490679
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
12. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
Zaffaroni N; De Polo D; Villa R; Della Porta C; Collini P; Fabbri A; Pilotti S; Daidone MG
J Pathol; 2003 Sep; 201(1):127-33. PubMed ID: 12950025
[TBL] [Abstract][Full Text] [Related]
14. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.
Kuenen-Boumeester V; Henzen-Logmans SC; Timmermans MM; van Staveren IL; van Geel A; Peeterse HJ; Bonnema J; Berns EM
J Pathol; 1999 Oct; 189(2):169-75. PubMed ID: 10547570
[TBL] [Abstract][Full Text] [Related]
16. [Small cell carcinoma and carcinoids of the lung: morphology of apoptosis and expression of biomolecular markers of tumor growth].
Pal'tsev MA; Demura SA; Kogan EA; Jack G; Zende B
Arkh Patol; 2000; 62(5):11-7. PubMed ID: 11076293
[TBL] [Abstract][Full Text] [Related]
17. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
Guo L; Zhou Y; Sun Y; Zhang F
Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
[TBL] [Abstract][Full Text] [Related]
18. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
Guo L; Chen P; Zhou Y; Sun Y
Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis.
Wang DG; Johnston CF; Anderson N; Sloan JM; Buchanan KD
J Pathol; 1995 Apr; 175(4):397-401. PubMed ID: 7790993
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.
Langlois NE; Lamb J; Eremin O; Heys SD
J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]